( BIOSCIENCE TECHNOLOGY) – Houston-based MolecularMatch, which launched its online platform two years ago to connect cancer patients to treatment options and clinical trials, has partnered with Liquid Biotech USA Inc., a personalized cancer diagnostics company, to advance early cancer detection and treatment.

MolecularMatch works with labs, hospitals and physicians to identify treatment options, such as clinical trial and experimental drugs, based on cancer patients’ genomic cancer data.  The company was founded in 2014 using technology licensed from the University of Texas MD Anderson Cancer Center.

See the full article HERE